{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:02:12Z","timestamp":1780412532503,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["No. H2021108003"],"award-info":[{"award-number":["No. H2021108003"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-024-03820-x","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T16:39:04Z","timestamp":1734626344000},"page":"2982-2992","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Preclinical study of TLR stimulation combined PD-1 antibody enhance the therapeutic effect of microwave ablation on NSCLC"],"prefix":"10.1007","volume":"27","author":[{"given":"Ying","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2190-4928","authenticated-orcid":false,"given":"Zhigang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"issue":"3","key":"3820_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"3820_CR2","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.jtho.2023.08.011","volume":"18","author":"Y Li","year":"2023","unstructured":"Li Y, Juergens RA, Finley C, Swaminath A. Current and Future Treatment Options in the Management of Stage III NSCLC. J Thorac Oncol. 2023;18(11):1478\u201391.","journal-title":"J Thorac Oncol"},{"key":"3820_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.semcancer.2019.10.019","volume":"68","author":"R Karuppasamy","year":"2021","unstructured":"Karuppasamy R, Veerappapillai S, Maiti S, Shin WH, Kihara D. Current progress and future perspectives of polypharmacology: From the view of non-small cell lung cancer. Semin Cancer Biol. 2021;68:84\u201391.","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"3820_CR4","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","volume":"27","author":"M Wang","year":"2021","unstructured":"Wang M, Herbst RS, Boshoff C. Toward personalized treatment approaches for non-small-cell lung cancer. Nat Med. 2021;27(8):1345\u201356.","journal-title":"Nat Med"},{"issue":"1","key":"3820_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12943-021-01312-y","volume":"20","author":"MY Li","year":"2021","unstructured":"Li MY, Liu LZ, Dong M. Progress on pivotal role and application of exosome in lung cancer carcinogenesis, diagnosis, therapy and prognosis. Mol Cancer. 2021;20(1):22.","journal-title":"Mol Cancer"},{"key":"3820_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.semcancer.2020.07.009","volume":"84","author":"SR Yang","year":"2022","unstructured":"Yang SR, Schultheis AM, Yu H, Mandelker D, Ladanyi M, B\u00fcttner R. Precision medicine in non-small cell lung cancer: Current applications and future directions. Semin Cancer Biol. 2022;84:184\u201398.","journal-title":"Semin Cancer Biol"},{"issue":"8 Suppl","key":"3820_CR7","doi-asserted-by":"publisher","first-page":"S192","DOI":"10.1016\/j.jvir.2010.04.007","volume":"21","author":"MG Lubner","year":"2010","unstructured":"Lubner MG, Brace CL, Hinshaw JL, Lee FT Jr. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol. 2010;21(8 Suppl):S192\u2013203.","journal-title":"J Vasc Interv Radiol"},{"issue":"2","key":"3820_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1148\/radiol.12111901","volume":"263","author":"W Zhou","year":"2012","unstructured":"Zhou W, Zha X, Liu X, et al. US-guided percutaneous microwave coagulation of small breast cancers: a clinical study. Radiology. 2012;263(2):364\u201373.","journal-title":"Radiology"},{"issue":"11","key":"3820_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143370","volume":"10","author":"F Ito","year":"2015","unstructured":"Ito F, Ku AW, Bucsek MJ, et al. Immune adjuvant activity of pre-resectional radiofrequency ablation protects against local and systemic recurrence in aggressive murine colorectal cancer. PLoS ONE. 2015;10(11): e0143370.","journal-title":"PLoS ONE"},{"issue":"3","key":"3820_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.diii.2017.12.011","volume":"99","author":"J Zhu","year":"2018","unstructured":"Zhu J, Yu M, Chen L, et al. Enhanced antitumor efficacy through microwave ablation in combination with immune checkpoints blockade in breast cancer: a pre-clinical study in a murine model. Diagn Interv Imaging. 2018;99(3):135\u201342.","journal-title":"Diagn Interv Imaging"},{"issue":"24","key":"3820_CR11","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1080\/15384101.2020.1853942","volume":"19","author":"X Duan","year":"2020","unstructured":"Duan X, Wang M, Han X, et al. Combined use of microwave ablation and cell immunotherapy induces nonspecific immunity of hepatocellular carcinoma model mice. Cell Cycle. 2020;19(24):3595\u2013607.","journal-title":"Cell Cycle"},{"issue":"2","key":"3820_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/15384101.2022.2112007","volume":"22","author":"RQ Guo","year":"2023","unstructured":"Guo RQ, Peng JZ, Li YM, Li XG. Microwave ablation combined with anti-PD-1\/CTLA-4 therapy induces an antitumor immune response to renal cell carcinoma in a murine model. Cell Cycle. 2023;22(2):242\u201354.","journal-title":"Cell Cycle"},{"issue":"6","key":"3820_CR13","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.90521","volume":"2","author":"MT Silvestrini","year":"2017","unstructured":"Silvestrini MT, Ingham ES, Mahakian LM, et al. Priming is key to effective incorporation of image-guided thermal ablation into immunotherapy protocols. JCI Insight. 2017;2(6): e90521.","journal-title":"JCI Insight"},{"issue":"1","key":"3820_CR14","first-page":"35","volume":"2","author":"KG Holste","year":"2019","unstructured":"Holste KG, Orringer DA. Laser interstitial thermal therapy. Neurooncol Adv. 2019;2(1):35.","journal-title":"Neurooncol Adv."},{"issue":"5","key":"3820_CR15","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1158\/1078-0432.CCR-15-1352","volume":"22","author":"L Shi","year":"2016","unstructured":"Shi L, Chen L, Wu C, et al. PD-1 Blockade Boosts Radiofrequency Ablation-Elicited Adaptive Immune Responses against Tumor. Clin Cancer Res. 2016;22(5):1173\u201384.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3820_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/00071668.2014.981146","volume":"56","author":"J Lin","year":"2015","unstructured":"Lin J, Kang H, Liang J, Fu J, Yu Q, Yang Q. CpG oligonucleotides and Astragalus polysaccharides are effective adjuvants in cultures of avian bone-marrow-derived dendritic cells. Br Poult Sci. 2015;56(1):30\u20138.","journal-title":"Br Poult Sci"},{"issue":"6","key":"3820_CR17","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.immuni.2022.07.021","volume":"49","author":"CS Garris","year":"2018","unstructured":"Garris CS, Arlauckas SP, Kohler RH, et al. Successful anti-PD-1 cancer immunotherapy requires t cell-dendritic cell crosstalk involving the cytokines IFN-\u03b3 and IL-12 [published correction appears in Immunity. 2022 Sep 13;55(9):1749]. Immunity. 2018;49(6):1148-1161.e7. https:\/\/doi.org\/10.1016\/j.immuni.2022.07.021.","journal-title":"Immunity"},{"issue":"7","key":"3820_CR18","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.3390\/biomedicines12071568","volume":"12","author":"WK Chang","year":"2024","unstructured":"Chang WK, Chen YT, Lin CP, et al. Cordycepin Augments the Efficacy of Anti-PD1 against Colon Cancer. Biomedicines. 2024;12(7):1568.","journal-title":"Biomedicines."},{"key":"3820_CR19","doi-asserted-by":"crossref","unstructured":"Zhu P, Li SY, Ding J, et al. Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C. J Pharm Anal. 2023;13(6):616-24.","DOI":"10.1016\/j.jpha.2023.04.012"},{"issue":"1","key":"3820_CR20","doi-asserted-by":"publisher","first-page":"8845","DOI":"10.1038\/s41467-024-53015-9","volume":"15","author":"P Bergeron","year":"2024","unstructured":"Bergeron P, Dos Santos M, Sitterle L, et al. Non-homogenous intratumor ionizing radiation doses synergize with PD1 and CXCR2 blockade. Nat Commun. 2024;15(1):8845.","journal-title":"Nat Commun"},{"issue":"4","key":"3820_CR21","first-page":"5271","volume":"15","author":"S Yuan","year":"2018","unstructured":"Yuan S, Qiao T, Li X, et al. Toll-like receptor 9 activation by CpG oligodeoxynucleotide 7909 enhances the radiosensitivity of A549 lung cancer cells via the p53 signaling pathway. Oncol Lett. 2018;15(4):5271\u20139.","journal-title":"Oncol Lett"},{"issue":"3","key":"3820_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.7150\/jca.12899","volume":"7","author":"W Sun","year":"2016","unstructured":"Sun W, Fang M, Chen Y, et al. Delivery system of CpG oligodeoxynucleotides through eliciting an effective T cell immune response against melanoma in mice. J Cancer. 2016;7(3):241\u201350.","journal-title":"J Cancer"},{"issue":"6","key":"3820_CR23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s10875-004-6244-3","volume":"24","author":"CL Cooper","year":"2004","unstructured":"Cooper CL, Davis HL, Morris ML, et al. CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I\/II study. J Clin Immunol. 2004;24(6):693\u2013701.","journal-title":"J Clin Immunol"},{"issue":"12","key":"3820_CR24","doi-asserted-by":"publisher","first-page":"6640","DOI":"10.1073\/pnas.1921445117","volume":"117","author":"X Wang","year":"2020","unstructured":"Wang X, Yang X, Zhang C, et al. Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy. Proc Natl Acad Sci U S A. 2020;117(12):6640\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3820_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack I, Shaw A. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2018;15:81\u201394.","journal-title":"Nat Rev Clin Oncol"},{"key":"3820_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12916-023-02852-4","volume":"21","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Edil BH, Li M. Combination therapies for cancer: challenges and opportunities. BMC Med. 2023;21:171.","journal-title":"BMC Med"},{"key":"3820_CR27","doi-asserted-by":"publisher","first-page":"1153066","DOI":"10.3389\/fonc.2023.1153066","volume":"13","author":"M Jiang","year":"2023","unstructured":"Jiang M, Fiering S, Shao Q. Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical trials. Front Oncol. 2023;13:1153066.","journal-title":"Front Oncol"},{"issue":"6","key":"3820_CR28","doi-asserted-by":"publisher","first-page":"29382","DOI":"10.1038\/srep29382","volume":"8","author":"J Chen","year":"2016","unstructured":"Chen J, Guo J, Chen Z, Wang J, Liu M, Pang X. Linifanib (ABT-869) potentiates the efficacy of chemotherapeutic agents through the suppression of receptor tyrosine kinase-mediated AKT\/mTOR signaling pathways in gastric cancer. Sci Rep. 2016;8(6):29382.","journal-title":"Sci Rep"},{"issue":"4","key":"3820_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002343","volume":"9","author":"W Zhou","year":"2021","unstructured":"Zhou W, Yu M, Pan H, et al. Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer. J Immunother Cancer. 2021;9(4): e002343.","journal-title":"J Immunother Cancer"},{"issue":"7","key":"3820_CR30","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1111\/cas.16182","volume":"115","author":"N He","year":"2024","unstructured":"He N, Huang H, Wu S, Ji W, Tai Y, Gao R, Liu Y, Liu Y, Chen L, Zhu D, Zheng X, Jiang J. Microwave ablation combined with PD-L1 blockade synergistically promotes Cxcl9-mediated antitumor immunity. Cancer Sci. 2024;115(7):2196\u2013208.","journal-title":"Cancer Sci"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03820-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-024-03820-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03820-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T14:35:12Z","timestamp":1750343712000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-024-03820-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["3820"],"URL":"https:\/\/doi.org\/10.1007\/s12094-024-03820-x","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare that there are no author conflicts and financial conflicts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Research Ethics Committee of The Second Hospital of Hebei Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have agreed the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}